Metastatic Papillary Renal Cell Carcinoma

Oncology·MeSH: Carcinoma, Renal Cell

Prevalence

48.0 / 100K

Incidence

15.0 / 100K/yr

0 drugs in development·0 companies·2 clinical trials

Frequently asked questions

How many clinical trials target Metastatic Papillary Renal Cell Carcinoma?

There are 2 clinical trials targeting Metastatic Papillary Renal Cell Carcinoma tracked by BioSniper.

What is the prevalence of Metastatic Papillary Renal Cell Carcinoma?

The estimated prevalence of Metastatic Papillary Renal Cell Carcinoma is approximately 48.0 per 100,000 population.

Deep-dive into Metastatic Papillary Renal Cell Carcinoma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Metastatic Papillary Renal Cell Carcinoma — Drugs in Development & Clinical Trials | BioSniper